Effects of the oral endothelin receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension

Authors:
  • NGNazzareno Galie
    Nazzareno Galie
  • AHAlan L. Hinderliter
    Alan L. Hinderliter
  • ATAdam Torbicki
    Adam Torbicki
  • GSGerald Simonneau
    Gerald Simonneau
  • NENilda Espinola-Zabaleta
    Nilda Espinola-Zabaleta
  • GRGuido Rocchi
    Guido Rocchi
  • MKMarcin Kurzyna
    Marcin Kurzyna
  • AKAndrew Kronenberg
    Andrew Kronenberg
  • RFRobert Frantz
    Robert Frantz
  • NSNagueh Sherif
    Nagueh Sherif
  • RBRobyn Barst
    Robyn Barst
  • KDKarl Dujardin
    Karl Dujardin

Abstract
No abstract available